Outcomes Associated with Brain Metastases in a Three-Arm Phase III Trial of Gemcitabine-Containing Regimens Versus Paclitaxel Plus Carboplatin for Advanced Non-small Cell Lung Cancer

Ries, 2006 Shepherd, 1993, Screening, diagnosis, and staging of lung cancer, Curr Opin Oncol, 5, 310, 10.1097/00001622-199303000-00010 Walling, 1994, Chemotherapy for advanced non-small-cell lung cancer, Respir Med, 88, 649, 10.1016/S0954-6111(05)80061-7 1995, Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials. Non-small Cell Lung Cancer Collaborative Group, BMJ, 311, 899, 10.1136/bmj.311.7010.899 Grilli, 1993, Chemotherapy for advanced non-small-cell lung cancer: how much benefit is enough?, J Clin Oncol, 11, 1866, 10.1200/JCO.1993.11.10.1866 Marino, 1994, Chemotherapy vs supportive care in advanced non-small-cell lung cancer. Results of a meta-analysis of the literature, Chest, 106, 861, 10.1378/chest.106.3.861 Souquet, 1993, Polychemotherapy in advanced non small cell lung cancer: a meta-analysis, Lancet, 342, 19, 10.1016/0140-6736(93)91882-M Rajeswaran, 2008, Lung Cancer, 59, 1, 10.1016/j.lungcan.2007.07.012 D'Addario, 2005, Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature, J Clin Oncol, 23, 2926, 10.1200/JCO.2005.03.045 Davey, 2002, Brain metastases: treatment options to improve outcomes, CNS Drugs, 16, 325, 10.2165/00023210-200216050-00005 Gaspar, 1997, Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials, Int J Radiat Oncol Biol Phys, 37, 745, 10.1016/S0360-3016(96)00619-0 Posner, 1992, Management of brain metastases, Rev Neurol (Paris), 148, 477 Wen, 1999, Management of brain metastases, Oncology (Williston Park), 13, 941 Newman, 1974, Proceedings: frequency, diagnosis, and treatment of brain metastases in 247 consecutive patients with bronchogenic carcinoma, Cancer, 33, 492, 10.1002/1097-0142(197402)33:2<492::AID-CNCR2820330225>3.0.CO;2-O Sorensen, 1988, Brain metastases in adenocarcinoma of the lung: frequency, risk groups, and prognosis, J Clin Oncol, 6, 1474, 10.1200/JCO.1988.6.9.1474 Lagerwaard, 1999, Identification of prognostic factors in patients with brain metastases: a review of 1292 patients, Int J Radiat Oncol Biol Phys, 43, 795, 10.1016/S0360-3016(98)00442-8 Sundstrom, 1998, Prognosis of patients treated for intracranial metastases with whole-brain irradiation, Ann Med, 30, 296, 10.3109/07853899809005858 Patchell, 1990, A randomized trial of surgery in the treatment of single metastases to the brain, N Engl J Med, 322, 494, 10.1056/NEJM199002223220802 Zimm, 1981, Intracerebral metastases in solid-tumor patients: natural history and results of treatment, Cancer, 48, 384, 10.1002/1097-0142(19810715)48:2<384::AID-CNCR2820480227>3.0.CO;2-8 Ferrarese, 2006, Treatment and prophylaxis for brain metastases from non-small cell lung cancer: whole brain radiation treatment versus stereotactic radiosurgery, Ann Oncol, 17, ii71, 10.1093/annonc/mdj929 Chang, 1992, Late survival of non-small cell lung cancer patients with brain metastases. Influence of treatment, Chest, 101, 1293, 10.1378/chest.101.5.1293 Oh, 2008, Systemic therapy for lung cancer brain metastases: a rationale for clinical trials, Oncology (Williston Park), 22, 168 Hochstenbag, 2003, MR-imaging of the brain of neurologic asymptomatic patients with large cell or adenocarcinoma of the lung. Does it influence prognosis and treatment?, Lung Cancer, 42, 189, 10.1016/S0169-5002(03)00291-5 Schellinger, 1999, Diagnostic accuracy of MRI compared to CCT in patients with brain metastases, J Neurooncol, 44, 275, 10.1023/A:1006308808769 Suzuki, 2004, Magnetic resonance imaging and computed tomography in the diagnoses of brain metastases of lung cancer, Lung Cancer, 46, 357, 10.1016/j.lungcan.2004.05.011 Chang, 2007, Therapeutic advances in the treatment of brain metastases, Clin Adv Hematol Oncol, 5, 54 Robinet, 2001, Results of a phase III study of early versus delayed whole brain radiotherapy with concurrent cisplatin and vinorelbine combination in inoperable brain metastasis of non-small-cell lung cancer: Groupe Francais de Pneumo-Cancerologie (GFPC) Protocol 95–1, Ann Oncol, 12, 59, 10.1023/A:1008338312647 Treat, 2005, J Clin Oncol, 23, 10.1200/jco.2005.23.16_suppl.lba7025 Treat, 2009, A randomized, phase III multicenter trial of gemcitabine in combination with carboplatin or paclitaxel versus paclitaxel plus carboplatin in patients with advanced or metastatic non-small-cell lung cancer, Ann Oncol Fleming, 1997 Kaplan, 1958, Nonparametric estimation of incomplete observations, J Am Stat Assoc, 53, 457, 10.1080/01621459.1958.10501452 Therasse, 2000, New guidelines to evaluate the response to treatement in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada, J Natl Cancer Inst, 92, 205, 10.1093/jnci/92.3.205 National Cancer Institute, 1999 O'Brien, 1979, A multiple testing procedure for clinical trials, Biometrics, 35, 549, 10.2307/2530245 Cox, 1989 Charloux, 1997, The increasing incidence of lung adenocarcinoma: reality or artefact? A review of the epidemiology of lung adenocarcinoma, Int J Epidemiol, 26, 14, 10.1093/ije/26.1.14 Ott, 1991, Measurements of blood-brain barrier permeability in patients undergoing radiotherapy and chemotherapy for primary cerebral lymphoma, Eur J Cancer, 27, 1356, 10.1016/0277-5379(91)90009-3 Stewart, 1988, Platinum concentrations in human autopsy tumor samples, Am J Clin Oncol, 11, 152, 10.1097/00000421-198804000-00013 Cotto, 1996, A phase II trial of fotemustine and cisplatin in central nervous system metastases from non-small cell lung cancer, Eur J Cancer, 32A, 69, 10.1016/0959-8049(95)00507-2 Minotti, 1998, Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer, Lung Cancer, 20, 93, 10.1016/S0169-5002(98)00021-X Lee, 2000, Paclitaxel and carboplatin chemotherapy as a primary treatment of brain metastases in patients with non-small cell lung cancer, Proc Am Soc Clin Oncol, 19 Srivastava, 2009, Risk of intracranial hemorrhage and cerebrovascular accidents in non-small cell lung cancer brain metastasis patients, J Thorac Oncol, 4, 333, 10.1097/JTO.0b013e318194fad4 Goodgame